Dr. Andrzej Jakubowiak, MD, PhD
Claim this profileUniversity Of Chicago Medicine Comprehensive Cancer Center
Studies Plasma Cell Neoplasm
Studies Multiple Myeloma
10 reported clinical trials
12 drugs studied
Area of expertise
1Plasma Cell Neoplasm
Serum protein electrophoresis (SPEP)/immunofixation studies (IFIX)
SPEP/IFIX
multi-color flow cytometry
2Multiple Myeloma
Serum protein electrophoresis (SPEP)/immunofixation studies (IFIX)
SPEP/IFIX
multi-color flow cytometry
Affiliated Hospitals
Clinical Trials Andrzej Jakubowiak, MD, PhD is currently running
More about Andrzej Jakubowiak, MD, PhD
Clinical Trial Related5 years of experience running clinical trials · Led 10 trials as a Principal Investigator · 1 Active Clinical TrialTreatments Andrzej Jakubowiak, MD, PhD has experience with
- Dexamethasone
- Carfilzomib
- Lenalidomide
- Daratumumab
- Ixazomib Citrate
- Screening Phase
Breakdown of trials Andrzej Jakubowiak, MD, PhD has run
Plasma Cell Neoplasm
Multiple Myeloma
Residual Disease
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Andrzej Jakubowiak, MD, PhD specialize in?
Andrzej Jakubowiak, MD, PhD focuses on Plasma Cell Neoplasm and Multiple Myeloma. In particular, much of their work with Plasma Cell Neoplasm has involved Serum protein electrophoresis (SPEP)/immunofixation studies (IFIX) patients, or patients who are SPEP/IFIX.
Is Andrzej Jakubowiak, MD, PhD currently recruiting for clinical trials?
Yes, Andrzej Jakubowiak, MD, PhD is currently recruiting for 1 clinical trial in Chicago Illinois. If you're interested in participating, you should apply.
Are there any treatments that Andrzej Jakubowiak, MD, PhD has studied deeply?
Yes, Andrzej Jakubowiak, MD, PhD has studied treatments such as Dexamethasone, Carfilzomib, Lenalidomide.
What is the best way to schedule an appointment with Andrzej Jakubowiak, MD, PhD?
Apply for one of the trials that Andrzej Jakubowiak, MD, PhD is conducting.
What is the office address of Andrzej Jakubowiak, MD, PhD?
The office of Andrzej Jakubowiak, MD, PhD is located at: University Of Chicago Medicine Comprehensive Cancer Center, Chicago, Illinois 60637 United States. This is the address for their practice at the University Of Chicago Medicine Comprehensive Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.